Product information

Current status:

Cancelled Post Market

Current status date:

2025-07-03

Original market date: ^{See footnote 1}

1995-12-31

Product name:

33.3% DEXTROSE INJECTION, USP

DIN:

02014831 Electronic product monograph is not available

Company:

BAXTER CORPORATION
7125 Mississauga Road
Mississauga
Ontario
Canada L5N 0C2

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intravenous

Number of active ingredient(s):

1

Schedule(s):

ETHICAL

American Hospital Formulary Service (AHFS): ^{See footnote 3}

40:20.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

B05BA03 CARBOHYDRATES

Active ingredient group (AIG) number:^{See footnote5}

0102181005